PM360 Acknowledges emtelligent's emtelliPro Medical AI Platform as "One of the Most Interesting Innovations of 2023"

PM360 is a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. They have selected emtelligent's ​ emtelliPro medical-grade AI platform for its annual Innovations Issue, which highlights the most interesting advancements in life sciences, healthcare, and marketing across 13 categories.

Read the full article here or below:

emtelligent has leveraged recent advances in artificial intelligence ​
(AI), large language models (LLMs), and large-scale data extraction ​
tools to build a modern medical natural language processing (NLP) ​
platform that truly is clinical grade. Unlike traditional medical NLP ​
software, the cloud-based emtelliPro platform wasn't written only by ​
machine learning experts: It was written by machine learning and NLP ​
experts in collaboration with doctors to ensure ​
high-quality information extraction. By tapping the experience and ​
expertise of clinical professionals who understand the medical jargon, ​
acronyms, and shorthand found in unstructured data – which comprises 80%
​ of all electronic health records data – emtelligent has created a ​
platform optimized for the specific needs of clinical and research ​
end-users. 

"As a practicing radiologist, I know that having relevant patient ​
data at the point of care leads to better outcomes, greater efficiency, ​
and lower healthcare costs," said Dr. Tim O'Connell,
​ emtelligent CEO and cofounder. "What we're building at emtelligent is ​
helping to transform healthcare, and we are proud that our emtelliPro ​
platform has been included in PM360's prestigious Innovations Issue." 

Now, in its 12th year, PM360's Innovations Issue is
​ published each December. This issue was established as the industry's ​
first-ever guide to the year's most innovative advancements and has ​
since become a premier resource. This year, the issue expanded to ​
include 13 categories: Artificial Intelligence; Clinical Trials; ​
Consumer Tech and Wellness; Core Business Processes; Data and ​
Cybersecurity; Employee Acquisition, Development, and Programs; Health ​
Technology Non-Consumer; Life Sciences; Marketing Technology or ​
Services; Metaverse; Payers/Insurance Companies; Startups; and ​
Telehealth/Telemedicine.

In total, 56 innovations were selected by PM360's editorial staff for inclusion in the issue out of hundreds of submissions. ​ 

"We know the importance of innovation, which is why we expanded this ​
issue to include the most fascinating and ground-breaking achievements ​
being made in all areas of life sciences, healthcare, and marketing," ​
says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360.
​ "The innovations we selected are changing how our industry operates to ​
create better ways to develop treatments, run companies, educate ​
physicians, improve diagnosis, and much more to ultimately find better ​
ways to serve patients."

All of this year's selections can be found at: https://www.pm360online.com/pm360-presents-the-2023-innovators.

 

 

 

 

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About emtelligent®

Based in Vancouver, BC, emtelligent® partners with healthcare institutions, companies and organizations to strategically structure their unstructured medical data, helping them increase safety, operating efficiency and the quality of care. The emtelliPro™ engine and emtelliSuite™ apps are available now, and the team is on-hand to consult regarding your medical data needs. Learn more or schedule a demonstration at www.emtelligent.com or call 1-877-GO-EMTEL (1-877-463-6835) today.

Contact

301-1110 Hamilton Street, Vancouver, BC V6B 2S2

1-877-463-6835

info@emtelligent.com

www.emtelligent.com